BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback